Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Clinical trial NCT01968668 · COMPLETED
Trial details
- NCT number
- NCT01968668
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-28
- Primary completion
- 2014-10-09
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.